Long-term surveillance study of rituximab originator treated patients with granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA).
Lisa UchidaRachel B JonesRona M SmithMarianna NodaleSimon BondClaudia LoechelMaria KingRaashid LuqmaniDavid GrayJoe BarrettDavid R W JaynePublished in: Rheumatology advances in practice (2024)
Over 40% of patients with AAV experienced at least one SAE. Although shorter time to first SAE and higher risk of infection were observed in the rituximab group, baseline imbalances necessitate a careful interpretation of these results.